Materion (MTRN) Q1 2025 earnings summary

Executive summary

• Net sales reached $420.3 million, up 9% year-over-year, with value-added sales of $259.3 million, a 1% increase driven by space, energy, and semiconductor markets, partially offset by lower PMI shipments.

• Net income rose 32% to $17.7 million ($0.85 per diluted share), with adjusted EPS up 18% to $1.13, driven by operational improvements and cost reductions.

• Record Q1 adjusted EBITDA margin of 18.8% (up 130 basis points), with adjusted EBITDA at $48.7 million, reflecting strong operational performance.

• Free cash flow improved by $35 million year-over-year, aided by reduced working capital and $27 million inventory reduction.

• Secured a multi-year agreement with Idaho National Lab to supply materials for nuclear energy R&D.

Financial highlights

• Value-added sales were $259.3 million, up 1% year-over-year, driven by growth in space, energy, and semiconductors.

• Adjusted EPS was $1.13, up 18% from prior year; net income margin on net sales was 4.2%.

• Adjusted EBITDA reached $48.7 million (18.8% of value-added sales), up 8% with 130 basis points margin expansion.

• Free cash flow improved to negative $5.5 million from negative $40.4 million year-over-year.

• Cash and cash equivalents stood at $15.6 million at quarter-end.

Outlook and guidance

• Full-year 2025 adjusted EPS guidance remains $5.30–$5.70, but unresolved global tariffs, especially with China, could impact results.

• Q2 expected to be slightly better than Q1, but with a $0.10–$0.15 EPS headwind from China tariffs; persistent tariffs could add $0.40–$0.50 EPS impact in the second half.

• Committed to achieving 20%+ adjusted EBITDA margin for the year, with a midterm target of 23%.

• Capital expenditures for 2025 expected to be approximately $70 million, reduced by $10 million from prior guidance.

• Management believes liquidity is sufficient to support operations, capital needs, and strategic initiatives for at least the next twelve months.